Capricor Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Capricor Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Capricor Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Capricor Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $395k | 83k | 4.77 |
| 2024-03-31 | $1.4M | 213k | 6.79 |
| 2023-12-31 | $75k | 15k | 4.89 |
| 2023-09-30 | $84k | 25k | 3.42 |
| 2023-06-30 | $117k | 25k | 4.78 |
| 2023-03-31 | $104k | 25k | 4.22 |
| 2022-12-31 | $95k | 25k | 3.86 |
| 2022-06-30 | $87k | 25k | 3.49 |
| 2022-03-31 | $145k | 42k | 3.43 |
| 2021-12-31 | $89k | 30k | 2.93 |
| 2021-09-30 | $89k | 22k | 4.02 |
| 2020-06-30 | $179k | 39k | 4.61 |